Antibody weapon against malaria shows promise in Africa
A new way to prevent malaria that showed promise in 9 U.S. volunteers deliberately exposed to parasite-laden mosquitoes last year has now shown its mettle in a real-world situation in Africa. A study published today in the
New England Journal of Medicine
showed that
a single dose
of lab-produced monoclonal antibodies can protect recipients from infection for up to 6 months during Mali’s intense malaria season.
Monoclonal antibodies are expensive to produce and can be cumbersome to administer if they are infused straight into the bloodstream. That makes some researchers skeptical that the new one...
Source: ScienceNOW - November 1, 2022 Category: Science Source Type: news
Africa: Vaccines Could Be a Game-Changer in the Fight Against Malaria in Africa
[The Conversation Africa] The development of an effective vaccine for malaria has proved to be far more challenging than developing a vaccine to protect people from COVID-19. Several different COVID-19 vaccines were developed and approved for use within a year of the disease's emergence. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 30, 2022 Category: Infectious Diseases Source Type: news
Malawi: Malawi Announces Rollout of Children's Malaria Vaccine
[VOA] Malawi's health ministry says it will soon roll out Africa's first malaria vaccine for children under age five. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - October 11, 2022 Category: Infectious Diseases Source Type: news
Street Medicine; Folic Acid for Suicidality; and Malaria Vaccines Street Medicine; Folic Acid for Suicidality; and Malaria Vaccines
The top 3 things you should know to start your day.3 Things to Know Today (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 5, 2022 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Can New Vaccines Finally Eradicate Malaria?
Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease. (Source: NYT Health)
Source: NYT Health - October 4, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli and Kang-Chun Cheng Tags: your-feed-science Vaccination and Immunization Malaria Disease Rates Children and Childhood Africa Mosquitoes Drugs (Pharmaceuticals) Third World and Developing Countries Philanthropy Parasites Clinical Trials Kenya Kisumu (Kenya Source Type: news
At Long Last, Can Malaria Be Eradicated?
Two new vaccines may finally turn back an ancient plague. But in unexpected ways, their arrival also complicates the path to ending the disease. (Source: NYT Health)
Source: NYT Health - October 4, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli and Kang-Chun Cheng Tags: your-feed-science Vaccination and Immunization Malaria Disease Rates Children and Childhood Africa Mosquitoes Drugs (Pharmaceuticals) Third World and Developing Countries Philanthropy Parasites Clinical Trials Kenya Kisumu (Kenya Source Type: news
News at a glance: Earth science satellites, Global Fund ’s haul, and Neptune’s rings
EARTH SCIENCE
European satellite duo will study oceans and warming
The European Space Agency (ESA) last week approved the $420 million Harmony mission as the next in its Earth Explorer line of science missions, following a competition. Harmony’s two satellites will carry infrared sensors and radar receivers to observe the turbulent waves, winds, and eddies that govern the interchange of heat and gases between the oceans and atmosphere. Scientists know oceans soak up more than 90% of the excess heat of global warming, but they need Harmony’s finer scale observations to explain how—and to calibra...
Source: ScienceNOW - September 29, 2022 Category: Science Source Type: news
DCGI allows Serum Institute to export malaria vaccine to UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK, official sources said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2022 Category: Pharmaceuticals Source Type: news
Africa: 'Best Yet' Malaria Vaccine Developers Eye 2023 Rollout
[SciDev.Net] Ouagadougou -- Researchers say they plan to roll out a new malaria vaccine next year after tests on children in West Africa found it to be up to 80 per cent effective. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 24, 2022 Category: Infectious Diseases Source Type: news
WHO grants prequalification to GSK's Mosquirix - the first and only approved malaria vaccine
GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking malaria vaccine. This is the first prequalification for a malaria vaccine and is an important step in rolling out the vaccine in countries with moderate to high P. falciparum malaria transmission. (Source: World Pharma News)
Source: World Pharma News - September 19, 2022 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
Africa: Malaria Vaccine - The Road Has Been Long and Tortuous, but We're Getting There
[The Conversation Africa] A vaccine candidate, called R21, has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 16, 2022 Category: Infectious Diseases Source Type: news
Africa: RBM Partnership Welcomes the Latest Malaria Vaccine Developments
[RBM] The RBM Partnership to End Malaria welcomes two crucial developments that aim to improve access to preventive malaria vaccines for children at risk of the disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 12, 2022 Category: Infectious Diseases Source Type: news
Malaria/vaccine development: injection of hope
Technology used to develop Covid vaccines may help in the fight against other diseases (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 10, 2022 Category: Pharmaceuticals Source Type: news
New malaria vaccine shows strong protection in global fight against deadly disease
Encouraging new data on a malaria vaccine from Oxford University bodes well for the global effort to combat the mosquito-borne disease that kills a child every minute, its makers said on Wednesday. (Source: CBC | Health)
Source: CBC | Health - September 8, 2022 Category: Consumer Health News Tags: News/Health Source Type: news
Malaria booster vaccine shows durable high efficacy in African children, meeting WHO-specified 75% efficacy goal
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ - which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021. (Source: World Pharma News)
Source: World Pharma News - September 8, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
